{"id":962007,"date":"2026-05-13T07:06:36","date_gmt":"2026-05-13T11:06:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/"},"modified":"2026-05-13T07:06:36","modified_gmt":"2026-05-13T11:06:36","slug":"corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/","title":{"rendered":"Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NORWOOD, Mass., May  13, 2026  (GLOBE NEWSWIRE) &#8212; Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on developing promising new therapies in oncology and obesity, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present a corporate overview and attend investor meetings at both the\u00a0<em>RBC Capital Markets Global Healthcare Conference<\/em> being held in New York on May 19 \u2013 20, 2026, and the <em>Jefferies Global Healthcare Conference<\/em> being held in New York on June 2 &#8211; 4, 2026.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\">\n            <strong>RBC Capital Markets Global Healthcare Conference<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:10%;width:10%;min-width:10%\">Format:<\/td>\n<td style=\"max-width:90%;width:90%;min-width:90%\">Presentation and one-on-one investor meetings<\/td>\n<\/tr>\n<tr>\n<td>Date:<\/td>\n<td>Tuesday, May 19, 2026<\/td>\n<\/tr>\n<tr>\n<td>Time:<\/td>\n<td>2:05pm EDT<\/td>\n<\/tr>\n<tr>\n<td>Webcast:<\/td>\n<td>\n            <a href=\"https:\/\/kvgo.com\/rbc\/corbus-pharmaceuticals-holdings-inc-may-2026\" rel=\"nofollow\" target=\"_blank\">Click here<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td colspan=\"2\">\n            <strong>Jefferies Global Healthcare Conference<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td>Format:<\/td>\n<td>Presentation and one-on-one investor meetings<\/td>\n<\/tr>\n<tr>\n<td>Date:<\/td>\n<td>Thursday, June 4, 2026<\/td>\n<\/tr>\n<tr>\n<td>Time:<\/td>\n<td>4:55pm EDT<\/td>\n<\/tr>\n<tr>\n<td>Webcast:<\/td>\n<td>\n            <a href=\"https:\/\/event.summitcast.com\/view\/NgCqua4VVQjq9ibVWHVWca\/guest_book?session_id=Mc5NJGL9nLMGprUzpZtoaU\" rel=\"nofollow\" target=\"_blank\">Click here<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">\n        <strong><br \/>\n          <br \/>About Corbus<\/strong>\n      <\/p>\n<p align=\"justify\">Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage company focused on developing promising new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing innovative scientific approaches to well-understood biological pathways. Corbus\u2019 pipeline includes CRB-701, a next-generation antibody drug conjugate for the treatment of Nectin-4-expressing tumors, and CRB-913, an orally delivered highly peripherally restricted CB1 inverse agonist for the treatment of obesity. Corbus is headquartered in Norwood, Massachusetts. For more information on Corbus, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kk2nXtX5jYXwws4g-DNF2JY2vXfluZEnKKJ_U8tVl-payFIA3KhZu-_PpuY8794m-7sXQ_CLCPQel5dCbDe09v-ZgLTY2TaaX4RGT_iL8w0G25W4j4qRb07SPvpwPMJsVfN9IOtztUAYX5gJliGK77jEmEy85htaWD2p14I8HOo85mmqRzTMjWoiWOq7p4Jxvz4tqNIHvQnswPpZ74CBtFfvGzdMkS5GRKlKN4VBi7Fm6NkJzV5uS4HiOZART7un5lymyPmIP9DVJGPyyJ-oVIVkuBPQhyh6dBSVMm7HJ8IymEx_uUkvnNPukbs4wBUozNrnohh0_zXl-GYeCaQqdCR1wyEJVQ-ydOp4d4FyKQc0MUhvn2GspCKTErOoX9XT-bxE6ua-oQ8Rgkw944PIBX-hz0ZwdjffXkjJtQnr1QGQ6tu42WNXnQp6f_7Ra85TL0O0h_NOx3SGqZswYSJhZDwOCXuFumk9OTSu4gzpcdc=\" rel=\"nofollow\" target=\"_blank\">corbuspharma.com<\/a>. Connect with us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DiMQJavhrkhWXBfdrkVHT5dPbsmPqyzRI_7y-Mk5JeNjOS7nnTMs_bwo10Kp9cEveisjueYqVINURGHDgV42EeslX3o_lqMZa7lAQAghfrgds0vxkhfrBkR3g0aOQLwSgGcGHKWZqfzr1ubGzQ_y15MoW2R7JEKQwxIKqaEXUv4Qch_XkDHI_4XKgtqJT26ZZ7GsH2kyyO-UF88nzHjtwh1iClAJW8F-z4Ct3t8UsO3GQ7w8MSL043WQKAVvQiXtR00tzPfrP4r2srf7KtWhO3jn4bHDDMcvbA9DciReB2UShlXPhRaePxw2sC1w7V0POQ_MVCi_ea9By1QuK61MFNHqlqvAfMxJv9sqWZc6GhL5a48-7vPnPO8HsA1D9QHr\" rel=\"nofollow\" target=\"_blank\">X<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MCL5PPrvhKEG5DM0soqc2nL3Dxb5kUqL6GHHyJFSBSILHjs5F-hHbBfaKbLZ4nDuIPniTgcY3fMb4BdMTcEnpbuR6TKqRQZZOKaH_qYfG068IC2rtQl0lD7bEk691V8Bl8lGeJTmJeFPVsW3u0jt1Cc5OH0enbgg-nINWHANN9Hlwyv5v5dRVm3IBM1Bc1iBIR6O2-N1Fpc_BN352KG36rvItHUhQ1_xwIEHcqP0ZRuzhGptOfKRAme97QrW6eTSw1mpKcsTAJ153sNgRyKKtZbrm0dz-kQZ4iy2tye_wB4ktDn30L8Qtn2hmPgMjOvVFIl5s1h25kUR9U48I_7U5yFLptYjEbO_5ALAOwFTLDjgQYBwHoUXR9zl6Sz9Nvv_l4mZoY5inXXIyvlQau7uyLmpRpj91LFo1-fwPfEouA9fHNVtkkTgf742tmWMtzHjMCNkcKAPLJ8M2zMOp3FxBd4ixtAGyszr1E3MtZrAWHc=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kQBVNIS7eco78k8wz7lGhVgl2kdlG1JXJIgjn1xMFXRg7P3X7npsiBWb7MTlQBdx3ybgnRubF4pJ1smyQ2bManZDvbUtbcv7_1s6gp0xFD88Dhjn8mpoKdYGJ2bVT6Pl6qCq8juVrXoe6ktcJFS82j7a2o2LsrXKPWkR3khnsU7LA6xy5lRn6FTkpxh94afZHZj7n-9oiRWkR5bFyHc8LGm6T_nAckBkfafx2dygILetOmkYIVOUxfbeqSfduoamLBFAITYjo4CSRaU131ikZzj1ltbBeu9Gsq-YVmxx8afGB4r6xQTFSYZpbxaZLT_ZIcVhjTwZZgqDZ2Vzzsc8mrkWPMwHM2xmjI9onPZe4pRGJfLOCDrFW2BgDLLXMtRzVgvA1Ntlvn40IibeipNKKP2ZD6KqN4GjvKU-x0PE1i8kojRiRjbG2fIjsvUbbFQJ\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act of 1995, as amended, including those relating to the Company\u2019s trial results, product development, clinical and regulatory timelines, including timing for completion of trials and presentation of data, anticipated regulatory interactions and outcomes, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities, sufficiency of cash runway and other statement that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management\u2019s current beliefs and assumptions.<\/p>\n<p align=\"justify\">These statements may be identified by the use of forward-looking expressions, including, but not limited to, \u201cexpect,\u201d \u201canticipate,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cshould,\u201d \u201cwould\u201d and similar expressions and the negatives of those terms. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors on our operations, clinical development plans and timelines, which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in the Company\u2019s filings with the Securities and Exchange Commission including those described in our Annual Report on Form 10-K for the year ended December 31, 2025. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.<\/p>\n<p align=\"justify\">All product names, logos, brands and company names are trademarks or registered trademarks of their respective owners. Their use does not imply affiliation or endorsement by these companies.<\/p>\n<p>\n        <strong>INVESTOR CONTACTS:<\/strong><br \/>\n        <br \/>Sean Moran<br \/>Chief Financial Officer<br \/>Corbus Pharmaceuticals<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yqGOyiMI5jgn-GgGmkqfYUqMIaKBgU74l9nLWzFVGOePq1PeC60Op9kkkc1CWMPPJIkvs--sfZsGp0-CIN7Pajk-clqN1dhPqqZ5ikMHKGiUF9nYCMUdzV5AgGIjjb4QN6RaFVmuqIG-eeqV0MvXDU3rA-wCugNLh1cj5OyVTSF-lOGWES3ScvU_2CVObRUW12T8Xh2SlhTDKM9jOOQ0NW-D8JLSjRRy0DrC_TmIOp_-7LwH7T-MwJekqIqmhViVMENttEdxVca73nhqHKaDVgSiKbdvxsEHWCrv763K2QY=\" rel=\"nofollow\" target=\"_blank\">smoran@corbuspharma.com<\/a><\/p>\n<p>Dan Ferry<br \/>Managing Director<br \/>LifeSci Advisors, LLC<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0JQ7GoNHPsJre_eY51YsGQgdwHg3Sq7bzhJY0ow7HQiK_K572F2IV-weXXd7AMqOl2Dl2k4Hjw7dW79HpJ2okCFAMkbp730teTmpmFBwFnRW-fRl98c18RU3GyzwZA7JK8B8-NuyAXJJINeTe7DOjzV7hINoz4ooHi-Gj9x5s9ou4ibFgd4I_5TqugenAnl2Qn6BgsEeZj0hJgUpkUF_uLpiEKg9BZGk7h9OitF_iCXhJ_BtYeYeCHo_jvvxQu84R5YBVJfs-MYe4oSb3ayPdEVYjMkK8dLcIZaSJAcjyiA=\" rel=\"nofollow\" target=\"_blank\">daniel@lifesciadvisors.com<\/a><\/p>\n<p>\n        <strong>MEDIA CONTACT:<\/strong><br \/>\n        <br \/>Liz Melone<br \/>Founder &amp; Principal<br \/>Melone Communications, LLC<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qqBbTIFD2L1ibi8WkAoSshyimbqDvdCEti_4EcIRPRQnTGLoSFcbX1bEyVJ1blk7Xp6VRYX2-8ZAllNCicBBMQiWFhstVHzTNNNnWcuI347h7lNNkC4X-wt6AWp_2GY915INYWhbrc7ns6cS5ZDaMhPCEQfm6qPjOpnA9FThezhklcAXObA8czrTvXmuqPwZxhT93Pd5bvp9lozTGrXue9OC5o9apqZDFU7k8V5ZhS9QyI34m2m08p95QQrDu5r3BgAaWijjlPDdz2tExAB-bg==\" rel=\"nofollow\" target=\"_blank\">liz@melonecomm.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxODg4MCM3NTk5NTgyIzUwMDExODg0MA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjZlNGRiYmEtOTlhYi00MGE4LTgwZTUtNGI4MzExZDRkYTkxLTUwMDExODg0MC0yMDI2LTA1LTEzLWVu\/tiny\/Corbus-Pharmaceuticals-Holding.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NORWOOD, Mass., May 13, 2026 (GLOBE NEWSWIRE) &#8212; Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on developing promising new therapies in oncology and obesity, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present a corporate overview and attend investor meetings at both the\u00a0RBC Capital Markets Global Healthcare Conference being held in New York on May 19 \u2013 20, 2026, and the Jefferies Global Healthcare Conference being held in New York on June 2 &#8211; 4, 2026. RBC Capital Markets Global Healthcare Conference Format: Presentation and one-on-one investor meetings Date: Tuesday, May 19, 2026 Time: 2:05pm EDT Webcast: Click here \u00a0 \u00a0 Jefferies Global Healthcare Conference Format: Presentation and one-on-one investor meetings Date: Thursday, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-962007","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NORWOOD, Mass., May 13, 2026 (GLOBE NEWSWIRE) &#8212; Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on developing promising new therapies in oncology and obesity, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present a corporate overview and attend investor meetings at both the\u00a0RBC Capital Markets Global Healthcare Conference being held in New York on May 19 \u2013 20, 2026, and the Jefferies Global Healthcare Conference being held in New York on June 2 &#8211; 4, 2026. RBC Capital Markets Global Healthcare Conference Format: Presentation and one-on-one investor meetings Date: Tuesday, May 19, 2026 Time: 2:05pm EDT Webcast: Click here \u00a0 \u00a0 Jefferies Global Healthcare Conference Format: Presentation and one-on-one investor meetings Date: Thursday, &hellip; Continue reading &quot;Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-13T11:06:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxODg4MCM3NTk5NTgyIzUwMDExODg0MA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-05-13T11:06:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\\\/\"},\"wordCount\":570,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxODg4MCM3NTk5NTgyIzUwMDExODg0MA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\\\/\",\"name\":\"Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxODg4MCM3NTk5NTgyIzUwMDExODg0MA==\",\"datePublished\":\"2026-05-13T11:06:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxODg4MCM3NTk5NTgyIzUwMDExODg0MA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxODg4MCM3NTk5NTgyIzUwMDExODg0MA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/","og_locale":"en_US","og_type":"article","og_title":"Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"NORWOOD, Mass., May 13, 2026 (GLOBE NEWSWIRE) &#8212; Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on developing promising new therapies in oncology and obesity, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present a corporate overview and attend investor meetings at both the\u00a0RBC Capital Markets Global Healthcare Conference being held in New York on May 19 \u2013 20, 2026, and the Jefferies Global Healthcare Conference being held in New York on June 2 &#8211; 4, 2026. RBC Capital Markets Global Healthcare Conference Format: Presentation and one-on-one investor meetings Date: Tuesday, May 19, 2026 Time: 2:05pm EDT Webcast: Click here \u00a0 \u00a0 Jefferies Global Healthcare Conference Format: Presentation and one-on-one investor meetings Date: Thursday, &hellip; Continue reading \"Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-13T11:06:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxODg4MCM3NTk5NTgyIzUwMDExODg0MA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences","datePublished":"2026-05-13T11:06:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/"},"wordCount":570,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxODg4MCM3NTk5NTgyIzUwMDExODg0MA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/","name":"Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxODg4MCM3NTk5NTgyIzUwMDExODg0MA==","datePublished":"2026-05-13T11:06:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxODg4MCM3NTk5NTgyIzUwMDExODg0MA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxODg4MCM3NTk5NTgyIzUwMDExODg0MA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/962007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=962007"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/962007\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=962007"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=962007"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=962007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}